Remove Cannabis Remove Conditions Remove Oil Remove Pharmaceutical
article thumbnail

Georgia Medical Cannabis Patients Can Now Purchase Cannabis Oil From Pharmacies

Veriheal

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. The Georgia State Board of Pharmacy recently made the decision to endorse more cannabis oil sale outlets. Eligible patients were granted access to low-THC marijuana oil.

Oil 98
article thumbnail

Prohibition Publish 2nd Ed Of The Pharmaceutical Cannabis Report

Cannabis Law Report

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can Cannabis Help Patients Titrate Off Other Pharmaceutical Drugs?

United Patients Group

Cannabis is a natural treatment for pain and other symptoms of withdrawal, and has been shown to help manage the side effects of drugs and even has be used as a substitute for prescription medications. Cannabis is a natural treatment for pain and other symptoms of withdrawal. Cannabis can help to manage the side effects of drugs.

article thumbnail

More Seniors Are Using Cannabis As Medicine

PrestoDoctor

The Use of Cannabis Among Seniors More and more seniors are turning to cannabis as an alternative to traditional medications. As the stigma surrounding cannabis use decreases and more research shows the potential benefits, older adults are exploring this natural remedy for various ailments.

article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

article thumbnail

Unlocking the Potential of CBD: Exploring The Benefits of CBD in Medical Marijuana

MMJ Recs

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52
article thumbnail

International Cannabis to Supply New Zealand’s NUBU Pharmaceuticals With Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products

Cannabis Law Report

ICC International Cannabis Corp. FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”).